Body Mass Index: Has Epidemiology Started to Break Down Causal Contributions to Health and Disease?

Overview

Journal Obesity (Silver Spring)

Specialties Endocrinology
Nutritional Sciences
Physiology

Date 2016 Jul 28

PMID 27460712

Citations 8

Authors

Laura J Corbin

Nicholas J Timpson

Affiliations

Soon will be listed here.

Abstract

Objectives: To review progress in understanding the methods and results concerning the causal contribution of body mass index (BMI) to health and disease.

Methods: In the context of conventional evidence focused on the relationship between BMI and health, this review considers current literature on the common, population-based, genetic contribution to BMI and how this has fed into the developing field of applied epidemiology.

Results: Technological and analytical developments have driven considerable success in identifying genetic variants relevant to BMI. This has enabled the implementation of Mendelian randomization to address questions of causality. The product of this work has been the implication of BMI as a causal agent in a host of health outcomes. Further breakdown of causal pathways by integration with other "omics" technologies promises to deliver additional benefit.

Conclusions: Gaps remain in our understanding of BMI as a risk factor for health and disease, and while promising, applied genetic epidemiology should be considered alongside alternative methods for assessing the impact of BMI on health. Potential limitations, relating to inappropriate or nonspecific measures of obesity and the improper use of genetic instruments, will need to be explored and incorporated into future research aiming to dissect BMI as a risk factor.

Citing Articles

Revising BMI Cut-Off Points for Overweight and Obesity in Male Athletes: An Analysis Based on Multivariable Model-Building.

Milanese C, Itani L, Cavedon V, Saadeddine D, Raggi S, Berri E Nutrients. 2025; 17(5).

PMID: 40077778 PMC: 11902134. DOI: 10.3390/nu17050908.

A multivariant recall-by-genotype study of the metabolomic signature of BMI.

Fang S, Wade K, Hughes D, FitzGibbon S, Yip V, Timpson N Obesity (Silver Spring). 2022; 30(6):1298-1310.

PMID: 35598895 PMC: 9324973. DOI: 10.1002/oby.23441.

Metabolic disorders and the risk of head and neck cancer: a protocol for a systematic review and meta-analysis.

Gormley A, Richards C, Spiga F, Gray E, Hooper J, Main B BMJ Open. 2022; 12(5):e058392.

PMID: 35508337 PMC: 9073393. DOI: 10.1136/bmjopen-2021-058392.

Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.

Fatima M, Ahmed I, Fakhro K, Al-Shabeeb Akil A Diabetes Obes Metab. 2021; 24(4):583-598.

PMID: 34882941 PMC: 9302617. DOI: 10.1111/dom.14618.

Changes in DNA Methylation and Gene Expression of Insulin and Obesity-Related Gene after Roux-en-Y Gastric Bypass.

Pinhel M, Noronha N, Nicoletti C, Pereira V, de Oliveira B, Cortes-Oliveira C Int J Mol Sci. 2020; 21(12).

PMID: 32599690 PMC: 7352760. DOI: 10.3390/ijms21124476.

References

Zacho J, Tybjaerg-Hansen A, Skov Jensen J, Grande P, Sillesen H, Nordestgaard B . Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008; 359(18):1897-908. DOI: 10.1056/NEJMoa0707402. View

Burgess S, Daniel R, Butterworth A, Thompson S . Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol. 2014; 44(2):484-95. PMC: 4469795. DOI: 10.1093/ije/dyu176. View

Zheng W, McLerran D, Rolland B, Zhang X, Inoue M, Matsuo K . Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011; 364(8):719-29. PMC: 4008249. DOI: 10.1056/NEJMoa1010679. View

Davey Smith G, Hemani G . Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014; 23(R1):R89-98. PMC: 4170722. DOI: 10.1093/hmg/ddu328. View

Groeneveld I, Proper K, van der Beek A, van Mechelen W . Sustained body weight reduction by an individual-based lifestyle intervention for workers in the construction industry at risk for cardiovascular disease: results of a randomized controlled trial. Prev Med. 2010; 51(3-4):240-6. DOI: 10.1016/j.ypmed.2010.07.021. View

Locke A, Kahali B, Berndt S, Justice A, Pers T, Day F . Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015; 518(7538):197-206. PMC: 4382211. DOI: 10.1038/nature14177. View

Holmes M, Lange L, Palmer T, Lanktree M, North K, Almoguera B . Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet. 2014; 94(2):198-208. PMC: 3928659. DOI: 10.1016/j.ajhg.2013.12.014. View

Timpson N, Sayers A, Davey-Smith G, Tobias J . How does body fat influence bone mass in childhood? A Mendelian randomization approach. J Bone Miner Res. 2008; 24(3):522-33. PMC: 2875165. DOI: 10.1359/jbmr.081109. View

Yajnik C, Yudkin J . The Y-Y paradox. Lancet. 2004; 363(9403):163. DOI: 10.1016/S0140-6736(03)15269-5. View

10.

Nordestgaard B, Palmer T, Benn M, Zacho J, Tybjaerg-Hansen A, Davey Smith G . The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med. 2012; 9(5):e1001212. PMC: 3341326. DOI: 10.1371/journal.pmed.1001212. View

11.

Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T . Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011; 342:d548. PMC: 3039696. DOI: 10.1136/bmj.d548. View

12.

Christou N, Sampalis J, Liberman M, Look D, Auger S, McLean A . Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240(3):416-23. PMC: 1356432. DOI: 10.1097/01.sla.0000137343.63376.19. View

13.

Maciejewski M, Livingston E, Smith V, Kavee A, Kahwati L, Henderson W . Survival among high-risk patients after bariatric surgery. JAMA. 2011; 305(23):2419-26. DOI: 10.1001/jama.2011.817. View

14.

Willi S, Hirst K, Jago R, Buse J, Kaufman F, El Ghormli L . Cardiovascular risk factors in multi-ethnic middle school students: the HEALTHY primary prevention trial. Pediatr Obes. 2012; 7(3):230-9. PMC: 3348358. DOI: 10.1111/j.2047-6310.2011.00042.x. View

15.

Stergiakouli E, Gaillard R, Tavare J, Balthasar N, Loos R, Taal H . Genome-wide association study of height-adjusted BMI in childhood identifies functional variant in ADCY3. Obesity (Silver Spring). 2014; 22(10):2252-9. PMC: 4265207. DOI: 10.1002/oby.20840. View

16.

Davey Smith G, Ebrahim S . Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004; 33(1):30-42. DOI: 10.1093/ije/dyh132. View

17.

Rodgers R, Tschop M, Wilding J . Anti-obesity drugs: past, present and future. Dis Model Mech. 2012; 5(5):621-6. PMC: 3424459. DOI: 10.1242/dmm.009621. View

18.

Ala-Korpela M, Kangas A, Soininen P . Quantitative high-throughput metabolomics: a new era in epidemiology and genetics. Genome Med. 2012; 4(4):36. PMC: 3446264. DOI: 10.1186/gm335. View

19.

Gray L, Cooper N, Dunkley A, Warren F, Ara R, Abrams K . A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. Obes Rev. 2012; 13(6):483-98. DOI: 10.1111/j.1467-789X.2011.00981.x. View

20.

Wells J . Commentary: The paradox of body mass index in obesity assessment: not a good index of adiposity, but not a bad index of cardio-metabolic risk. Int J Epidemiol. 2014; 43(3):672-4. PMC: 4052141. DOI: 10.1093/ije/dyu060. View